266 related articles for article (PubMed ID: 37927508)
1. Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis.
Li X; Huang X; Lei L; Tong S
Front Nutr; 2023; 10():1233973. PubMed ID: 37927508
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenic obesity and therapeutic outcomes in gastrointestinal surgical oncology: A meta-analysis.
Wang P; Wang S; Ma Y; Li H; Liu Z; Lin G; Li X; Yang F; Qiu M
Front Nutr; 2022; 9():921817. PubMed ID: 35938099
[TBL] [Abstract][Full Text] [Related]
3. Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Jiang C; Wang Y; Fu W; Zhang G; Feng X; Wang X; Wang F; Zhang L; Deng Y
Front Nutr; 2022; 9():978110. PubMed ID: 36590214
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review.
Stangl-Kremser J; Mari A; Lai LY; Lee CT; Vince R; Zaslavsky A; Salami SS; Fajkovic H; Shariat SF; Palapattu GS
J Urol; 2021 Oct; 206(4):854-865. PubMed ID: 34032495
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.
Mintziras I; Miligkos M; Wächter S; Manoharan J; Maurer E; Bartsch DK
Int J Surg; 2018 Nov; 59():19-26. PubMed ID: 30266663
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: A systematic review and meta-analysis.
Gao Q; Hu K; Gao J; Shang Y; Mei F; Zhao L; Chen F; Ma B
Nutrition; 2022 Sep; 101():111704. PubMed ID: 35696740
[TBL] [Abstract][Full Text] [Related]
7. The impact of sarcopenic obesity on treatment outcomes in gastrointestinal cancer: A systematic review.
Dikova TS; Zatsepina AY; Fedorinov DS; Lyadov VK
Clin Nutr ESPEN; 2022 Feb; 47():135-146. PubMed ID: 35063193
[TBL] [Abstract][Full Text] [Related]
8. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
9. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia predicts worse postoperative outcomes and decreased survival rates in patients with colorectal cancer: a systematic review and meta-analysis.
Trejo-Avila M; Bozada-Gutiérrez K; Valenzuela-Salazar C; Herrera-Esquivel J; Moreno-Portillo M
Int J Colorectal Dis; 2021 Jun; 36(6):1077-1096. PubMed ID: 33481108
[TBL] [Abstract][Full Text] [Related]
11. The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis.
Kovač MB; Pavlin T; Čavka L; Ribnikar D; Spazzapan S; Templeton AJ; Šeruga B
J Geriatr Oncol; 2023 Sep; 14(7):101594. PubMed ID: 37482497
[TBL] [Abstract][Full Text] [Related]
12. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis.
He J; Huang Y; Huang N; Jiang J
Front Oncol; 2024; 14():1363843. PubMed ID: 38571501
[TBL] [Abstract][Full Text] [Related]
15. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia is a Prognostic Biomarker for Long-Term Survival after Endovascular Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.
Dakis K; Nana P; Brodis A; Kouvelos G; Behrendt CA; Giannoukas A; Kölbel T; Spanos K
Ann Vasc Surg; 2022 Jul; 83():358-368. PubMed ID: 35288290
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis.
Xiong J; Chen K; Huang W; Huang M; Cao F; Wang Y; Chen Q
Front Oncol; 2023; 13():1249353. PubMed ID: 37869092
[TBL] [Abstract][Full Text] [Related]
18. Value of sarcopenia in the resection of colorectal liver metastases-a systematic review and meta-analysis.
Wagner D; Wienerroither V; Scherrer M; Thalhammer M; Faschinger F; Lederer A; Hau HM; Sucher R; Kornprat P
Front Oncol; 2023; 13():1241561. PubMed ID: 37841447
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
